Tokai Pharmaceuticals Inc

-

Assets, Funds, Holdings

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Tokai Pharmaceuticals Inc
CIK #0001404281
EDGAR Form CIK 2011 - 2026
10-K [0001404281]
10-Q [0001404281]
3 [0001404281]
4 [0001404281]
8-K [0001404281]
D [0001404281]
SC 13D [0001404281]
SC 13G [0001404281]
Form 13D/13G Filer Form 13D/13G Subject Filed
BlackRock Inc Eledon Pharmaceuticals Inc [2026-04-27]
Coastlands Capital LP Eledon Pharmaceuticals Inc [2025-11-24]
Vanguard Group Inc Eledon Pharmaceuticals Inc [2025-07-29]
BlackRock Inc Eledon Pharmaceuticals Inc [2025-07-17]
RA Capital Management LP Eledon Pharmaceuticals Inc [2024-11-05]
Frazier Life Sciences Public Fund LP Eledon Pharmaceuticals Inc [2024-11-05]
Armistice Capital LLC Eledon Pharmaceuticals Inc [2024-02-14]
Woodline Partners LP Eledon Pharmaceuticals Inc [2021-02-16]
FMR LLC Eledon Pharmaceuticals Inc [2021-02-08]
Adage Capital Partners GP LLC Eledon Pharmaceuticals Inc [2021-01-04]
View All
Form 3/4/5 Subject 2011 - 2026
Tokai Pharmaceuticals Inc
McBride John S
Robinson James A Jr
Lee June
Katkin Keith
Kirk Allan
Hillson Jan
Smith Bryan E
Gros David-Alexandre C
Little Paul Sean
Perrin Steven
BVF Inc/IL
Biotechnology Value Trading Fund OS LP
BVF Partners L P/IL
Lampert Mark N
BVF GP Holdings LLC
BVF II GP LLC
BVF Partners OS Ltd
Biotechnology Value Fund L P
Biotechnology Value Fund II LP
BVF I GP LLC
Lyons Gary A
Ogier Walter C
OrbiMed Israel GP Ltd
OrbiMed Israel BioFund GP Limited Partnership
Logos Global Management LP
Kuwahara Jon
Turkel Catherine C
Flesher Gregory J
Chimovits Erez
Cohen Cheryl
Lifesci Index Partners LLC
YOOK Paul
Morrison Jodie Pope
Ocampo Christine
Buckley Stephen Jr
Harrison Seth Loring
Barberich Timothy J
Yanchik Joseph A III
Kessler David A
Ferrante Karen Jean
Kalowski Lee
Quirk Gerald E
Novartis AG
Novartis BioVentures Ltd
Satter Muneer A
ATP Life Science Ventures LP
Apple Tree Partners II - Annex LP
Apple Tree Partners II LP
Thomas Robert Bain
Wade Denis Newell
Williams Martin D
Warman Investments Pty Ltd
Stewart Susan B
QBF No 2 Pty Ltd as trustee for Queensland BioCapital Fund
QBF No 1 Pty Ltd as trustee for Queensland BioCapital Fund
Platt Jon B
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Tokai Pharmaceuticals Inc ELDN
Common Stock
2026-01-10 Option exercise 3,430 $0.00
Tokai Pharmaceuticals Inc ELDN
Common Stock
2026-01-10 Option exercise 8,575 $0.00
Tokai Pharmaceuticals Inc ELDN
Common Stock
2026-01-10 Option exercise 3,430 $0.00
Tokai Pharmaceuticals Inc ELDN
Common Stock
2026-01-10 Option exercise 3,430 $0.00
Tokai Pharmaceuticals Inc ELDN
Common Stock
2026-01-10 Option exercise 3,430 $0.00
Tokai Pharmaceuticals Inc ELDN
Common Stock
2026-01-10 Option exercise 3,430 $0.00
Tokai Pharmaceuticals Inc ELDN
Restricted Stock Units · derivative
2026-01-10 Option exercise 3,430 $0.00
Tokai Pharmaceuticals Inc ELDN
Restricted Stock Units · derivative
2026-01-10 Option exercise 3,430 $0.00
Tokai Pharmaceuticals Inc ELDN
Restricted Stock Units · derivative
2026-01-10 Option exercise 3,430 $0.00
Tokai Pharmaceuticals Inc ELDN
Restricted Stock Units · derivative
2026-01-10 Option exercise 8,575 $0.00
Tokai Pharmaceuticals Inc ELDN
Restricted Stock Units · derivative
2026-01-10 Option exercise 3,430 $0.00
Tokai Pharmaceuticals Inc ELDN
Restricted Stock Units · derivative
2026-01-10 Option exercise 3,430 $0.00
Tokai Pharmaceuticals Inc ELDN
Restricted Stock Units · derivative
2025-01-10 Grant 3,430 $0.00
Tokai Pharmaceuticals Inc ELDN
Stock Option (right to buy) · derivative
2025-01-10 Grant 30,870 $0.00
Tokai Pharmaceuticals Inc ELDN
Restricted Stock Units · derivative
2025-01-10 Grant 3,430 $0.00
Tokai Pharmaceuticals Inc ELDN
Stock Option (right to buy) · derivative
2025-01-10 Grant 30,870 $0.00
Tokai Pharmaceuticals Inc ELDN
Restricted Stock Units · derivative
2025-01-10 Grant 66,500 $0.00
Tokai Pharmaceuticals Inc ELDN
Stock Option (right to buy) · derivative
2025-01-10 Grant 600,000 $0.00
Tokai Pharmaceuticals Inc ELDN
Stock Option (right to buy) · derivative
2025-01-10 Grant 150,500 $0.00
Tokai Pharmaceuticals Inc ELDN
Restricted Stock Units · derivative
2025-01-10 Grant 64,500 $0.00
showing 20 of 200 most recent transactions
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com